UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (65852) 65852
Newsletter (1382) 1382
Dissertation (292) 292
Book Chapter (258) 258
Conference Proceeding (86) 86
Magazine Article (76) 76
Publication (67) 67
Newspaper Article (50) 50
Web Resource (20) 20
Government Document (13) 13
Book / eBook (12) 12
Book Review (8) 8
Reference (6) 6
Journal / eJournal (4) 4
Streaming Video (4) 4
Poster (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (45136) 45136
science & technology (38349) 38349
life sciences & biomedicine (36112) 36112
cisplatin (28745) 28745
female (27581) 27581
cisplatin - administration & dosage (25098) 25098
male (23812) 23812
oncology (21537) 21537
middle aged (19930) 19930
antineoplastic combined chemotherapy protocols - therapeutic use (19170) 19170
aged (16364) 16364
adult (15896) 15896
chemotherapy (13343) 13343
animals (12180) 12180
cisplatin - pharmacology (11901) 11901
cancer (11896) 11896
cisplatin - therapeutic use (9554) 9554
cisplatin - adverse effects (8549) 8549
combined modality therapy (7513) 7513
antineoplastic agents - pharmacology (7502) 7502
treatment outcome (7485) 7485
cell line, tumor (6826) 6826
mice (6287) 6287
apoptosis (6237) 6237
antineoplastic combined chemotherapy protocols - adverse effects (6171) 6171
lung neoplasms - drug therapy (6052) 6052
neoplasm staging (5669) 5669
fluorouracil - administration & dosage (5372) 5372
research (5332) 5332
antineoplastic agents - therapeutic use (5165) 5165
pharmacology & pharmacy (4992) 4992
prognosis (4734) 4734
care and treatment (4717) 4717
survival rate (4615) 4615
drug administration schedule (4216) 4216
apoptosis - drug effects (4196) 4196
ovarian neoplasms - drug therapy (4138) 4138
doxorubicin - administration & dosage (4028) 4028
antineoplastic agents - administration & dosage (3921) 3921
carcinoma, squamous cell - drug therapy (3891) 3891
etoposide - administration & dosage (3782) 3782
antineoplastic combined chemotherapy protocols - administration & dosage (3766) 3766
dose-response relationship, drug (3677) 3677
analysis (3668) 3668
retrospective studies (3626) 3626
biochemistry & molecular biology (3608) 3608
cisplatin - toxicity (3497) 3497
carcinoma, non-small-cell lung - drug therapy (3474) 3474
aged, 80 and over (3367) 3367
survival analysis (3308) 3308
disease-free survival (3273) 3273
tumors (3251) 3251
follow-up studies (3202) 3202
antineoplastic agents (3178) 3178
drug resistance (3176) 3176
rats (3150) 3150
drug resistance, neoplasm (3061) 3061
chemotherapy, adjuvant (3053) 3053
lung neoplasms - pathology (3052) 3052
abridged index medicus (3030) 3030
time factors (3021) 3021
ovarian cancer (3018) 3018
health aspects (2939) 2939
tumor cells, cultured (2847) 2847
adolescent (2846) 2846
cell survival - drug effects (2844) 2844
antineoplastic agents - adverse effects (2827) 2827
surgery (2761) 2761
cell biology (2728) 2728
adenocarcinoma - drug therapy (2708) 2708
cancer therapies (2701) 2701
antimitotic agents (2675) 2675
lung cancer (2665) 2665
radiotherapy (2654) 2654
deoxycytidine - analogs & derivatives (2616) 2616
cyclophosphamide - administration & dosage (2495) 2495
medicine & public health (2454) 2454
proteins (2442) 2442
paclitaxel - administration & dosage (2385) 2385
metastasis (2331) 2331
stomach neoplasms - drug therapy (2307) 2307
ovarian neoplasms - pathology (2298) 2298
vinblastine - administration & dosage (2295) 2295
chemistry (2283) 2283
carcinoma, squamous cell - pathology (2260) 2260
physical sciences (2200) 2200
bleomycin - administration & dosage (2156) 2156
gene expression (2137) 2137
prospective studies (2137) 2137
toxicity (2137) 2137
drug therapy (2132) 2132
cell proliferation - drug effects (2103) 2103
deoxycytidine - administration & dosage (2077) 2077
dna damage (2041) 2041
carboplatin - administration & dosage (2018) 2018
drug synergism (2017) 2017
remission induction (2014) 2014
head and neck neoplasms - drug therapy (1916) 1916
neoplasms - drug therapy (1908) 1908
cytotoxicity (1901) 1901
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (62110) 62110
Japanese (4686) 4686
Chinese (1301) 1301
French (826) 826
German (717) 717
Russian (363) 363
Spanish (277) 277
Korean (235) 235
Portuguese (208) 208
Italian (207) 207
Polish (125) 125
Czech (51) 51
Hungarian (48) 48
Dutch (38) 38
Turkish (37) 37
Persian (22) 22
Bulgarian (19) 19
Ukrainian (16) 16
Danish (12) 12
Hebrew (12) 12
Romanian (12) 12
Serbian (7) 7
Slovak (7) 7
Croatian (6) 6
Lithuanian (6) 6
Norwegian (6) 6
Swedish (4) 4
Finnish (3) 3
Arabic (2) 2
Bosnian (2) 2
Indonesian (2) 2
Amharic (1) 1
Catalan (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 01/2019, Volume 393, Issue 10166, pp. 51 - 60
The incidence of human papillomavirus (HPV)-positive oropharyngeal cancer, a disease affecting younger patients, is rapidly increasing. Cetuximab, an epidermal... 
yes | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Oropharyngeal Neoplasms - therapy | Chemoradiotherapy - adverse effects | Humans | Middle Aged | Squamous Cell Carcinoma of Head and Neck - pathology | Male | Antineoplastic Agents - therapeutic use | Oropharyngeal Neoplasms - pathology | Antineoplastic Agents - administration & dosage | Cetuximab - therapeutic use | Radiotherapy, Intensity-Modulated - adverse effects | Squamous Cell Carcinoma of Head and Neck - virology | Cetuximab - adverse effects | Cisplatin - administration & dosage | Antineoplastic Agents - adverse effects | Female | Acute Disease | Chemoradiotherapy - methods | Papillomavirus Infections - complications | Drug Administration Schedule | Risk Assessment | Radiotherapy, Intensity-Modulated - methods | Kaplan-Meier Estimate | Treatment Outcome | Oropharyngeal Neoplasms - virology | Cisplatin - therapeutic use | Cisplatin - adverse effects | Cetuximab - administration & dosage | Squamous Cell Carcinoma of Head and Neck - therapy | Neoplasm Staging | Papillomaviruses | Radiotherapy | Throat cancer | Papillomavirus infections | Head | Intravenous administration | Toxicity | Health risks | Risk | Radiation therapy | FDA approval | Cancer therapies | Patients | Evidence-based medicine | Cisplatin | Quality of life | Human papillomavirus | Randomization | Epidermal growth factor | Oropharyngeal cancer | Head and neck | Head & neck cancer | Growth factors | Smoking | Cancer | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 10/2017, Volume 99, Issue 2, pp. S42 - S42
Journal Article
PloS one, ISSN 1932-6203, 11/2012, Volume 7, Issue 11, pp. e48752 - e48752
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 09/2013, Volume 31, Issue 27, pp. 3327 - 3334
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 12/2009, Volume 106, Issue 52, pp. 22199 - 22204
Journal Article